Suppr超能文献

抗氧化维生素和矿物质补充剂用于延缓年龄相关性黄斑变性的进展。

Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.

作者信息

Evans Jennifer R, Lawrenson John G

机构信息

Cochrane Eyes and Vision Group, ICEH, London School of Hygiene & Tropical Medicine, London, UK.

出版信息

Cochrane Database Syst Rev. 2012 Nov 14;11:CD000254. doi: 10.1002/14651858.CD000254.pub3.

Abstract

BACKGROUND

It has been proposed that antioxidants may prevent cellular damage in the retina by reacting with free radicals that are produced in the process of light absorption. Higher dietary levels of antioxidant vitamins and minerals may reduce the risk of progression of age-related macular degeneration (AMD).

OBJECTIVES

The objective of this review was to assess the effects of antioxidant vitamin or mineral supplementation on the progression of AMD in people with AMD.

SEARCH METHODS

We searched CENTRAL (which contains the Cochrane Eyes and Vision Group Trials Register) (The Cochrane Library 2012, Issue 8), Ovid MEDLINE, Ovid MEDLINE In-Process and Other Non-Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE (January 1946 to August 2012), EMBASE (January 1980 to August 2012), Allied and Complementary Medicine Database (AMED) (January 1985 to August 2012), OpenGrey (System for Information on Grey Literature in Europe) (www.opengrey.eu/), the metaRegister of Controlled Trials (mRCT) (www.controlled-trials.com), ClinicalTrials.gov (www.clinicaltrials.gov) and the WHO International Clinical Trials Registry Platform (ICTRP) (www.who.int/ictrp/search/en). We did not use any date or language restrictions in the electronic searches for trials. We last searched the electronic databases on 20 August 2012. We searched the reference lists of identified reports and the Science Citation Index. We contacted investigators and experts in the field for details of unpublished studies. We also searched for systematic reviews of harms of vitamin supplements.

SELECTION CRITERIA

We included randomised trials comparing antioxidant vitamin or mineral supplementation (alone or in combination) to placebo or no intervention in people with AMD.

DATA COLLECTION AND ANALYSIS

Two authors assessed risk of bias and extracted data from the included trials. Where appropriate, we pooled data using a random-effects model unless three or fewer trials were available in which case we used a fixed-effect model.

MAIN RESULTS

Thirteen trials (6150 participants) were included in this review. Over half the participants (3640) were randomised in one trial (AREDS in the USA), which found a beneficial effect of antioxidant (beta-carotene, vitamin C and vitamin E) and zinc supplementation on progression to advanced AMD (adjusted odds ratio (OR) 0.68, 95% confidence interval (CI) 0.53 to 0.87) over an average of 6.3 years. People taking supplements were less likely to lose 15 or more letters of visual acuity (adjusted OR 0.77, 95% CI 0.62 to 0.96). The other trials, in general, had shorter follow-up (less than two years). No evidence for an effect of supplementation was seen in these smaller trials of shorter duration. Overall we considered the strength of the evidence to be moderate. We did not consider included trials, in general, to be at risk of bias, although we found it difficult to assess reporting biases. The main reason for downgrading the strength of the evidence was because, for several analyses, only one trial was included and therefore consistency of the findings could not be assessed. The included trials reported the following adverse effects: hospitalisation for genito-urinary problems was more common in people taking zinc and yellowing of skin was more common in people taking antioxidants. Systematic searching of the literature identified other potential harms of vitamin supplementation, in particular an increased risk of lung cancer in smokers associated with beta-carotene supplements, but we were unable to identify a good systematic review of the evidence for harms of nutritional supplementation.

AUTHORS' CONCLUSIONS: People with AMD may experience delay in progression of the disease with antioxidant vitamin and mineral supplementation. This finding is drawn from one large trial conducted in a relatively well-nourished American population. The generalisability of these findings to other populations is not known. Although generally regarded as safe, vitamin supplements may have harmful effects. A systematic review of the evidence on harms of vitamin supplements is needed.

摘要

背景

有人提出抗氧化剂可通过与光吸收过程中产生的自由基发生反应来防止视网膜细胞受损。饮食中抗氧化维生素和矿物质水平较高可能会降低年龄相关性黄斑变性(AMD)进展的风险。

目的

本综述的目的是评估补充抗氧化维生素或矿物质对患有AMD的人AMD进展的影响。

检索方法

我们检索了Cochrane系统评价数据库(CENTRAL)(其中包含Cochrane Eyes and Vision Group试验注册库)(《Cochrane图书馆》2012年第8期)、Ovid MEDLINE、Ovid MEDLINE In-Process及其他未索引引文、Ovid MEDLINE日报、Ovid OLDMEDLINE(1946年1月至2012年8月)、EMBASE(1980年1月至2012年8月)、联合与补充医学数据库(AMED)(1985年1月至2012年8月)、OpenGrey(欧洲灰色文献信息系统)(www.opengrey.eu/)、对照试验元注册库(mRCT)(www.controlled-trials.com)、ClinicalTrials.gov(www.clinicaltrials.gov)以及世界卫生组织国际临床试验注册平台(ICTRP)(www.who.int/ictrp/search/en)。在电子检索试验时,我们未使用任何日期或语言限制。我们最后一次检索电子数据库是在2012年8月20日。我们检索了已识别报告的参考文献列表以及科学引文索引。我们联系了该领域的研究人员和专家以获取未发表研究的详细信息。我们还检索了关于维生素补充剂危害的系统评价。

选择标准

我们纳入了比较补充抗氧化维生素或矿物质(单独或联合使用)与安慰剂或不干预对患有AMD的人的随机试验。

数据收集与分析

两位作者评估偏倚风险并从纳入的试验中提取数据。在适当情况下,我们使用随机效应模型汇总数据,除非可用试验为三项或更少,此时我们使用固定效应模型。

主要结果

本综述纳入了13项试验(6150名参与者)。超过一半的参与者(3640名)在一项试验(美国的年龄相关性眼病研究(AREDS))中被随机分组,该试验发现抗氧化剂(β-胡萝卜素、维生素C和维生素E)和锌补充剂在平均6.3年的时间里对进展为晚期AMD有有益作用(调整后的比值比(OR)为0.68,95%置信区间(CI)为0.53至0.87)。服用补充剂的人视力下降15个或更多字母的可能性较小(调整后的OR为0.77,95%CI为0.62至0.96)。其他试验总体上随访时间较短(少于两年)。在这些持续时间较短的较小试验中未发现补充剂有效果的证据。总体而言,我们认为证据强度为中等。我们一般不认为纳入的试验存在偏倚风险,尽管我们发现难以评估报告偏倚。降低证据强度的主要原因是,对于多项分析,仅纳入了一项试验,因此无法评估结果的一致性。纳入的试验报告了以下不良反应:服用锌的人因泌尿生殖系统问题住院更为常见,服用抗氧化剂的人皮肤发黄更为常见。对文献的系统检索发现了维生素补充剂的其他潜在危害,特别是与β-胡萝卜素补充剂相关的吸烟者患肺癌风险增加,但我们未能找到关于营养补充剂危害证据的良好系统评价。

作者结论

患有AMD的人补充抗氧化维生素和矿物质可能会延缓疾病进展。这一发现来自于在美国一个营养状况相对良好的人群中进行的一项大型试验。这些发现对其他人群的适用性尚不清楚。尽管维生素补充剂通常被认为是安全的,但可能有有害影响。需要对维生素补充剂危害的证据进行系统评价。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验